Vol 27, No 2 (2022)
Technical note
Published online: 2022-03-02

open access

Page views 4840
Article views/downloads 299
Get Citation

Connect on Social Media

Connect on Social Media

Hybrid split-arc partial-field volumetric modulated arc therapy: an improved beam arrangement for linear accelerator-based hippocampal-avoidance whole brain radiation therapy

Adams Hei Long Yuen12, Po Man Wu1, Alex Kai Leung Li2, Philip Chung Yin Mak2
Rep Pract Oncol Radiother 2022;27(2):352-359.

Abstract

Background: This technical note aims to verify the hippocampus and adjacent organs at risk (OARs) sparing ability of an improved beam arrangement, namely hybrid split-arc partial-field volumetric modulated arc therapy (VMAT) (Hsapf-VMAT) during whole brain radiation therapy (WBRT).

Materials and methods: Computed tomography simulation images of 22 patients with brain metastases were retrieved in this retrospective planning study. The hippocampus was manually delineated according to the criterion of RTOG 0933. Plans delivering 30 Gy in 10 fractions were generated for each patient using split-arc partial-field VMAT (sapf-VMAT) and Hsapf-VMAT. The sapf-VMAT plans consisted of 4 arc fields of 179.9° each with reduced field size. The Hsapf-VMAT consisted of 4 arc fields similar to sapf-VMAT in addition to 2 lateral opposing static fields. Statistical comparisons between treatment plans of both techniques were performed using the paired t-test at 5% level significance.

Results: The results demonstrated that Hsapf-VMAT can achieve superior dose sparing in hippocampus which is comparable to sapf-VMAT (p > 0.05). In both eyes, Hsapf-VMAT had significantly lower Dmean and Dmax compared to sapf-VMAT (p < 0.005). Decrease in Dmax of both lenses using Hsapf-VMAT (p < 0.005) were statistically significant when compared to sapf-VMAT. Hsapf-VMAT demonstrated significant reduction of Dmean and Dmedian to the optic nerves (p < 0.05). Whole brain planning target volume (PTV) coverage was not compromised in both techniques.

Conclusion: The present study adopts a hybrid technique, namely Hsapf-VMAT, for hippocampal sparing WBRT. Hsapf-VMAT can achieve promising dose reduction to the hippocampus, both eyes and lenses. Therefore, Hsapf-VMAT can be considered an improved version of sapf-VMAT.

Article available in PDF format

View PDF Download PDF file

References

  1. Gondi V, Pugh SL, Tome WA, et al. Preservation of memory with conformal avoidance of the hippocampal neural stem-cell compartment during whole-brain radiotherapy for brain metastases (RTOG 0933): a phase II multi-institutional trial. J Clin Oncol. 2014; 32(34): 3810–3816.
  2. Yuen AH, Wu PoM, Li AK, et al. Volumetric modulated arc therapy (VMAT) for hippocampal-avoidance whole brain radiation therapy: planning comparison with Dual-arc and Split-arc partial-field techniques. Radiat Oncol. 2020; 15(1): 42.
  3. Hsu CR, Tai MC, Chang YH, et al. Rapid onset of radiation maculopathy after whole-brain radiation therapy: A case report. Medicine (Baltimore). 2016; 95(39): e4830.
  4. Tobillo R, Pearlstein K, Mahbooba Z, et al. Dry eye after whole brain radiation: Analysis from a prospective study. J Clin Oncol. 2018; 36(34_suppl): 198–198.
  5. Park J, Park JW, Yea JiW. Non-coplanar whole brain radiotherapy is an effective modality for parotid sparing. Yeungnam Univ J Med. 2019; 36(1): 36–42.
  6. Wang K, Tobillo R, Mavroidis P, et al. Prospective Assessment of Patient-Reported Dry Eye Syndrome After Whole Brain Radiation. Int J Radiat Oncol Biol Phys. 2019; 105(4): 765–772.
  7. Finger PT. Radiation therapy for orbital tumors: concepts, current use, and ophthalmic radiation side effects. Surv Ophthalmol. 2009; 54(5): 545–568.
  8. Finger PT. Radiation retinopathy is treatable with anti-vascular endothelial growth factor bevacizumab (Avastin). Int J Radiat Oncol Biol Phys. 2008; 70(4): 974–977.
  9. Scoccianti S, Detti B, Gadda D, et al. Organs at risk in the brain and their dose-constraints in adults and in children: a radiation oncologist's guide for delineation in everyday practice. Radiother Oncol. 2015; 114(2): 230–238.
  10. Jeganathan VS, Wirth A, MacManus MP. Ocular risks from orbital and periorbital radiation therapy: a critical review. Int J Radiat Oncol Biol Phys. 2011; 79(3): 650–659.
  11. Wagner D, Christiansen H, Wolff H, et al. Radiotherapy of malignant gliomas: comparison of volumetric single arc technique (RapidArc), dynamic intensity-modulated technique and 3D conformal technique. Radiother Oncol. 2009; 93(3): 593–596.
  12. Wolff D, Stieler F, Welzel G, et al. Volumetric modulated arc therapy (VMAT) vs. serial tomotherapy, step-and-shoot IMRT and 3D-conformal RT for treatment of prostate cancer. Radiother Oncol. 2009; 93(2): 226–233.
  13. Chan OSH, Lee MCH, Hung AWM, et al. The superiority of hybrid-volumetric arc therapy (VMAT) technique over double arcs VMAT and 3D-conformal technique in the treatment of locally advanced non-small cell lung cancer--a planning study. Radiother Oncol. 2011; 101(2): 298–302.
  14. Wang BH, Hua W, Gu X, et al. Dosimetric study of different radiotherapy planning approaches for hippocampal avoidance whole-brain radiation therapy (HA-WBRT) based on fused CT and MRI imaging. Australas Phys Eng Sci Med. 2015; 38(4): 767–775.
  15. International Commission on Radiation Units and Measurements Report 83. Prescribing, recording, and reporting photon-beam intensity-modulated radiation therapy (IMRT). J ICRU. 2010; 10.
  16. Martel MK, Sandler HM, Cornblath WT, et al. Dose-volume complication analysis for visual pathway structures of patients with advanced paranasal sinus tumors. Int J Radiat Oncol Biol Phys. 1997; 38(2): 273–284.
  17. Andreas JJ, Kundapur V. Hippocampus Avoidance Whole-brain Radiation Therapy: A Practical Intensity-modulated Radiation Therapy Planning and Delivery Approach to RTOG 0933. J Med Imaging Radiat Sci. 2015; 46(1): 78–84.
  18. Panet-Raymond V, Ansbacher W, Zavgorodni S, et al. Coplanar versus noncoplanar intensity-modulated radiation therapy (IMRT) and volumetric-modulated arc therapy (VMAT) treatment planning for fronto-temporal high-grade glioma. J Appl Clin Med Phys. 2012; 13(4): 3826.
  19. De Ruysscher D, Faivre-Finn C, Moeller D, et al. Lung Group and the Radiation Oncology Group of the European Organization for Research and Treatment of Cancer (EORTC). European Organisation for Research and Treatment of Cancer recommendations for planning and delivery of high-dose, high-precision radiotherapy for lung cancer. J Clin Oncol. 2010; 28(36): 5301–5310.
  20. Rong Yi, Evans J, Xu-Welliver M, et al. SU-E-T-581: Planning Evaluation of Step-And-Shoot IMRT, RapidArc and Helical TomoTherapy for Hippocampal-Avoidance Whole Brain Radiotherapy (HA-WBRT). Med Phys. 2012; 39(6Part19): 3839.
  21. Yang ZX, Shen JT, Li YP, et al. Rapid Health Technology Assessment Working Group of Chinese Evidence-Based Medicine Centre. Helical tomotherapy for cancer treatment: a rapid health technology assessment. J Evid Based Med. 2014; 7(3): 192–218.
  22. Bartel F, van Herk M, Vrenken H, et al. Inter-observer variation of hippocampus delineation in hippocampal avoidance prophylactic cranial irradiation. Clin Transl Oncol. 2019; 21(2): 178–186.
  23. Konopka-Filippow M, Sierko E, Wojtukiewicz M. Benefits and difficulties during brain radiotherapy planning with hippocampus sparing. Oncol Clin Pract. 2019; 15(2): 104–110.



Reports of Practical Oncology and Radiotherapy